HKU Scholars Hub: Browsing DSpace

Browsing by Author Jang, JW

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 3 to 7 of 7 < previous

	Title	Author(s)	Issue Date	Views
	Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos(t)ide analogue (NA)-naïve CHB patients: phase 2a, randomized, double-blind, placebo-controlled study. Proceeding/Conference:Journal of Hepatology	Yuen, RMF Heo, J Jang, JW Yoon, J-H Kweon, YO Park, S-J Bennett, F Kwoh, J	2020	1
	Impact of Alzheimer's Disease in Nine Asian Countries Journal:Gerontology	Yang, YH Meguro, K Kim, SY Shim, YS Yu, X Chen, CLH Wang, H Lam, L Senanarong, V Dominguez, J Lu, PY Lin, YT Hu, CJ Chiu, PY Fuh, JL Wang, WF Yu, BC Li, T Wang, MW Situmeang, RFV Jang, JW Zhang, J Chan, WC Zhou, YY Lou, H Zhang, L Ye, M Chen, X	2016	29
	Inarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response Proceeding/Conference:Hepatology	Yuen, RMF Elkhashab, M Chen, CY Chen, YF Coffin, CS Fung, SK Greenbloom, S Jang, JW Jeng, WJ Kim, DJ Kim, YJ Kim, W Lee, KS Lim, YS Liu, CJ Ramji, A Iyer, R Macfarlane, C Jackson, K Locarnini, S Afdhal, NH Chan, HLY ACHIEVE STUDY Investigators,	2018	7
	Phase 2a, randomized, double-blind, placebo-controlled study of an antisense inhibitor (ISIS 505358) in treatment-naïve chronic hepatitis B (CHB) patients: safety and antiviral efficacy Proceeding/Conference:Hepatology	Yuen, RMF Heo, J Jang, JW Yoon, JH Kweon, YO Park, SJ Bennett, CF Kwoh, TJ	2019	2
	Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer Journal:Oncogene	Lee, KS Lee, YS Lee, JM Ito, K Cinghu, S Kim, JH Jang, JW Li, YH Goh, YM Chi, XZ Wee, H Lee, HW Hosoya, A Chung, JH Jang, JJ Kundu, JK Surh, YJ Kim, WJ Ito, Y Jung, HS Bae, SC	2010

Showing results 3 to 7 of 7 < previous